The Siena-based company is a leader in biomedical imaging for the study of Alzheimer’s and multiple sclerosis
SIENA.
Siena Imaging will also be present at the 2024 edition of ‘Annual Outsourcing in Clinical Trials Europe’, scheduled to take place in Barcelona tomorrow, Tuesday 7 May, and Wednesday 8 May. The event will bring together leading international pharmaceutical and biotechnology companies and leading clinical trials professionals in Spain to share knowledge and discuss clinical and technological innovations.
Siena Imaging will bring to Barcelona the experience gained on a global scale in the field of biomedical imaging, thanks to its collaboration with major pharmaceutical companies to evaluate the effectiveness of new drugs tested in clinical trials. Since 2017, in fact, Siena Imaging has been an established reality in the field of the development of brain image indices, software and volumetric analyses functional to the study of the development of brain pathologies such as multiple sclerosis and Alzheimer’s. Representing Siena Imaging will be Chiara Gentile, Quality Manager, Irina Efimenko and Irene Giganti, Project Manager.
Siena Imaging flies to Spain for Annual Outsourcing of Clinical Trials
